BioInvent International AB (BINV) NPV
Sell:26.60 SEKBuy:26.70 SEK
0.10 SEK
(0.37%)
- This stock can be held in a
Stocks and Shares ISA0.10 SEK
(0.37%)0.10 SEK
(0.37%)Company Information
About this company
BioInvent International AB is a Sweden-based biopharmaceutical company, that develops antibody-based drugs for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of haematological cancer and solid tumors. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The Company has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
Key people
Key facts
- EPIC-
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINSE0015244520
- Market capSEK 1.76bn
- Employees115
- Shares in issue65.80m
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.